Get 40% Off
🚨 Markets Are Down. Unlock Undervalued StocksFind Stocks Now

Medasys SA (DEDAL)

Paris
Currency in EUR
Disclaimer
0.8000
0.0000(0.00%)
Closed
DEDAL Scorecard
Fair Value
Unlock Value
Day's Range
0.80000.8040
52 wk Range
0.00000.8040
Prev. Close
0.79
Open
0.8
Day's Range
0.8-0.804
52 wk Range
0-0
Volume
0
Average Vol. (3m)
38,237
1-Year Change
0%
Shares Outstanding
112,305,896
Fair Value
Unlock
Dividends Payment Streak
Unlock
Technical
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Daily
Weekly
Monthly
More
How do you feel today about DEDAL?
Vote to see community's results!
or

Medasys SA Company Profile

Dedalus France S.A. provides software solutions and services for healthcare institutions in France and internationally. The company offers DxCare suite that streamlines healthcare processes through the acquisition, management, and centralization of data in the patient records; and 4Health solutions suite for medicine. It also provides KaliSil, KaliLab, and Odancio solutions for biology and anapath/genetics/genome laboratories; and DxPharm solution, including drug and oncology circuits, and chemotherapy dispensing robot for pharmacy/oncology. In addition, the company offers imaging solutions and collaborative tools, and care territories; and DxUniversity, which provides customers training programs, as well as support and maintenance, hosting/ASP/SaaS, and outsourcing services. The company was formerly known as Medasys S.A. and changed its name to Dedalus France S.A. in March 2019. The company is based in Le Plessis Robinson, France.

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.